January 2, 2018 / 5:59 PM / Updated 4 minutes ago BRIEF-Aceto's Unit Launches Efavirenz Capsules, 50Mg, 200Mg Reuters Staff 
Jan 2 (Reuters) - Aceto Corp: 
* ACETO SUBSIDIARY, RISING PHARMACEUTICALS, LAUNCHES EFAVIRENZ CAPSULES, 50MG AND 200MG 
* SAYS UNIT ‍LAUNCHED GENERIC FOR EFAVIRENZ CAPSULES, AN FDA-APPROVED GENERIC VERSION OF REFERENCE LISTED DRUG SUSTIVA FROM BRISTOL MYERS SQUIBB​ Source text for Eikon: Further company coverage: